News

Extension of Distribution Agreement with Hoya Pentax Medical for the Asia-Pacific (APAC) region

Creo Medical Education Programme to be initiated in APAC alongside Market Seeding beginning in Australia.

Read More

First placement and use of Speedboat in South Africa

Seven upper GI tract patients successfully treated

Read More

Improving patient outcomes with Speedboat RS2 – An Eye Witness Account

Creo Medical is focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. Our mission is to improve patient outcomes by applying microwave and radiowave energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides physicians with flexible, accurate and controlled surgical solutions.

It was with great pride that Creo’s Chief Executive Officer, Craig Gulliford, recently witnessed, first hand, Creo’s Speedboat RS2 device, powered by Creo’s CROMA platform, being used to remove a large lesion from the lower bowel of a patient.

Read More

Creo Medical’s flotation awarded

Deal of the Year at the 2017 Insider Wales Dealmakers Awards

Read More

US FDA Approval of Speedboat RS2

Approval comes ahead of schedule; Company to implement commercial plans

Read More